Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva (FOP).

PubWeight™: 1.72‹?› | Rank: Top 3%

🔗 View Article (PMC 2669159)

Published in J Bone Miner Res on March 01, 2008

Authors

Paul C Billings1, Jennifer L Fiori, Jennifer L Bentwood, Michael P O'Connell, Xiangyang Jiao, Burton Nussbaum, Robert J Caron, Eileen M Shore, Frederick S Kaplan

Author Affiliations

1: The Center for Research in FOP and Related Disorders, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Articles citing this

BMP type I receptor inhibition reduces heterotopic [corrected] ossification. Nat Med (2008) 4.20

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81

Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg Med Chem Lett (2008) 2.51

The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest (2009) 2.18

Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol (2010) 1.87

Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone (2008) 1.53

Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2010) 1.51

Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res (2012) 1.49

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev (2013) 1.37

Restoration of normal BMP signaling levels and osteogenic differentiation in FOP mesenchymal progenitor cells by mutant allele-specific targeting. Gene Ther (2011) 1.28

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech (2012) 1.18

Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. J Biol Chem (2010) 1.18

The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal (2010) 1.16

The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev (2009) 1.11

Inactivation of Msx1 and Msx2 in neural crest reveals an unexpected role in suppressing heterotopic bone formation in the head. Dev Biol (2010) 1.03

Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells (2014) 1.02

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Proc Natl Acad Sci U S A (2015) 0.96

When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov Today Ther Strateg (2008) 0.94

Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis (2013) 0.94

Hyperactive BMP signaling induced by ALK2(R206H) requires type II receptor function in a Drosophila model for classic fibrodysplasia ossificans progressiva. Dev Dyn (2012) 0.92

FRET reveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface. Biophys J (2009) 0.91

Potential roles for the small leucine-rich proteoglycans biglycan and fibromodulin in ectopic ossification of tendon induced by exercise and in modulating rotarod performance. Scand J Med Sci Sports (2009) 0.89

Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol (2012) 0.89

TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res (2016) 0.88

From mysteries to medicines: drug development for fibrodysplasia ossificans progressive. Expert Opin Orphan Drugs (2013) 0.88

Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A (2010) 0.87

Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis. Ann N Y Acad Sci (2011) 0.87

Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Curr Osteoporos Rep (2011) 0.87

Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva. Methods Enzymol (2010) 0.85

Higher BMP/Smad sensitivity of tendon-derived stem cells (TDSCs) isolated from the collagenase-induced tendon injury model: possible mechanism for their altered fate in vitro. BMC Musculoskelet Disord (2013) 0.81

Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another? Wiley Interdiscip Rev Dev Biol (2013) 0.80

Granting immunity to FOP and catching heterotopic ossification in the Act. Semin Cell Dev Biol (2015) 0.78

Heterotopic ossification after the use of recombinant human bone morphogenetic protein-7. World J Orthop (2017) 0.77

Excess BMP Signaling in Heterotopic Cartilage Forming in Prg4-null TMJ Discs. J Dent Res (2015) 0.77

Bone morphogenetic protein signaling: implications in urology. Korean J Urol (2010) 0.77

Wnt and BMP Signaling Crosstalk in Regulating Dental Stem Cells: Implications in Dental Tissue Engineering. Genes Dis (2016) 0.76

Urine-derived induced pluripotent stem cells as a modeling tool to study rare human diseases. Intractable Rare Dis Res (2016) 0.75

Surgical excision of heterotopic ossification of hip in a rare case of Moyamoya disease with extra articular ankylosis. Indian J Orthop (2012) 0.75

Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling. J Bone Miner Res (2016) 0.75

Does Blast Medium Affect Heterotopic Ossification in a Blast-amputation Model? Clin Orthop Relat Res (2015) 0.75

Evaluation of metabolomic changes as a biomarker of chondrogenic differentiation in 3D-cultured human mesenchymal stem cells using proton (1H) nuclear magnetic resonance spectroscopy. PLoS One (2013) 0.75

Extracellular Matrix Mediates BMP-2 in a Model of Temporomandibular Joint Osteoarthritis. Cells Tissues Organs (2017) 0.75

Articles cited by this

Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94

Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A (2000) 11.41

Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol (2003) 7.74

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet (2006) 7.05

SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A (2003) 6.80

Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev (2003) 3.85

Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord (2006) 3.25

Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell (2007) 3.23

Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circ Res (2005) 3.16

Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med (1996) 2.94

A new population of human adult dental pulp stem cells: a useful source of living autologous fibrous bone tissue (LAB). J Bone Miner Res (2005) 2.24

Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol (2006) 1.99

A phylogenetically conserved cis-regulatory module in the Msx2 promoter is sufficient for BMP-dependent transcription in murine and Drosophila embryos. Development (2004) 1.94

Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am (2007) 1.83

Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem (2005) 1.82

Potassium-dependent assembly of coated pits: new coated pits form as planar clathrin lattices. J Cell Biol (1986) 1.77

Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res (2007) 1.68

In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells (2003) 1.67

ALK2 functions as a BMP type I receptor and induces Indian hedgehog in chondrocytes during skeletal development. J Bone Miner Res (2003) 1.66

An approachable human adult stem cell source for hard-tissue engineering. J Cell Physiol (2006) 1.53

Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am (2003) 1.49

Kinetics and inhibition of alkaline phosphatases from canine tissues. Biochim Biophys Acta (1972) 1.41

Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res (2005) 1.38

Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res (2006) 1.36

BMP4 inhibits proliferation and promotes myocyte differentiation of lung fibroblasts via Smad1 and JNK pathways. Am J Physiol Lung Cell Mol Physiol (2004) 1.09

Lipid raft-dependent endocytosis of metallothionein in HepG2 cells. J Cell Physiol (2007) 0.86

Articles by these authors

A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet (2006) 7.05

Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med (2010) 4.88

Singleton vaginal breech delivery at term: still a safe option. Obstet Gynecol (2004) 3.95

VEGF links hippocampal activity with neurogenesis, learning and memory. Nat Genet (2004) 3.60

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med (2003) 3.57

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med (2002) 3.31

The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem (2007) 3.24

Heterotopic ossification. J Am Acad Orthop Surg (2004) 2.96

Iatrogenic harm caused by diagnostic errors in fibrodysplasia ossificans progressiva. Pediatrics (2005) 2.92

Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat (2009) 2.81

Fibrodysplasia ossificans progressiva. Best Pract Res Clin Rheumatol (2008) 2.64

Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanoma. Nat Genet (2009) 2.58

Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am (2009) 2.53

The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization. J Clin Invest (2009) 2.18

Early diagnosis of fibrodysplasia ossificans progressiva. Pediatrics (2008) 2.02

Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis (2011) 1.98

Constitutively activated ALK2 and increased SMAD1/5 cooperatively induce bone morphogenetic protein signaling in fibrodysplasia ossificans progressiva. J Biol Chem (2008) 1.88

Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol (2010) 1.87

Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am (2007) 1.83

Developmental anomalies of the cervical spine in patients with fibrodysplasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine (Phila Pa 1976) (2005) 1.81

Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol (2004) 1.69

Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res (2007) 1.68

Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. Nat Med (2013) 1.66

The face signature of fibrodysplasia ossificans progressiva. Am J Med Genet A (2012) 1.62

Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2008) 1.59

In vivo somatic cell gene transfer of an engineered Noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am (2003) 1.59

Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone (2008) 1.53

Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Eur J Pediatr (2010) 1.52

Early mortality and cardiorespiratory failure in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2010) 1.51

Paresis of a bone morphogenetic protein-antagonist response in a genetic disorder of heterotopic skeletogenesis. J Bone Joint Surg Am (2003) 1.49

Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP). J Bone Miner Metab (2008) 1.41

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res (2008) 1.41

Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of BMPRIA. J Bone Miner Res (2005) 1.38

Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons. Pediatr Endocrinol Rev (2013) 1.37

Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP). J Bone Miner Res (2006) 1.36

Influenza-like viral illnesses and flare-ups of fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (2004) 1.35

Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells (2009) 1.32

Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol (2009) 1.32

A new era for fibrodysplasia ossificans progressiva: a druggable target for the second skeleton. Expert Opin Biol Ther (2007) 1.30

Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem (2006) 1.30

Stromal cells of fibrodysplasia ossificans progressiva lesions express smooth muscle lineage markers and the osteogenic transcription factor Runx2/Cbfa-1: clues to a vascular origin of heterotopic ossification? J Pathol (2003) 1.25

Morphogen receptor genes and metamorphogenes: skeleton keys to metamorphosis. Ann N Y Acad Sci (2007) 1.22

Substance P signaling mediates BMP-dependent heterotopic ossification. J Cell Biochem (2011) 1.21

Dysregulation of the BMP-4 signaling pathway in fibrodysplasia ossificans progressiva. Ann N Y Acad Sci (2006) 1.19

Fibrodysplasia ossificans progressiva: mechanisms and models of skeletal metamorphosis. Dis Model Mech (2012) 1.18

Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am J Hum Genet (2002) 1.18

An Acvr1 R206H knock-in mouse has fibrodysplasia ossificans progressiva. J Bone Miner Res (2012) 1.17

The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev (2009) 1.11

Insulin and glucagon regulate pancreatic α-cell proliferation. PLoS One (2011) 1.08

PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci (2009) 1.08

Effect of fetal sex on labour and delivery: retrospective review. BMJ (2003) 1.07

Filamin A modulates kinase activation and intracellular trafficking of epidermal growth factor receptors in human melanoma cells. Endocrinology (2009) 1.03

Alk2 regulates early chondrogenic fate in fibrodysplasia ossificans progressiva heterotopic endochondral ossification. Stem Cells (2014) 1.02

Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells. J Biol Chem (2009) 1.01

Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res (2010) 1.00

Methadone and perinatal outcomes: a prospective cohort study. Addiction (2012) 0.98

CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol (2012) 0.95

In vitro analyses of the dysregulated R206H ALK2 kinase-FKBP12 interaction associated with heterotopic ossification in FOP. Cells Tissues Organs (2011) 0.95

Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva. Clin Orthop Relat Res (2003) 0.94

Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J Bone Miner Res (2011) 0.94

High-throughput screening for modulators of mesenchymal stem cell chondrogenesis. Ann Biomed Eng (2008) 0.94

When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP). Drug Discov Today Ther Strateg (2008) 0.94

Impact of sterilization on the porous design and cell behavior in collagen sponges prepared for tissue engineering. Biomaterials (2002) 0.94

Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration. Blood (2009) 0.93

HSPG modulation of BMP signaling in fibrodysplasia ossificans progressiva cells. J Cell Biochem (2007) 0.92

Progressive osseous heteroplasia in the face of a child. Am J Med Genet A (2003) 0.89

Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol (2012) 0.89